Table 2.
Response | R2 | Model1 | Model2 | Model3 |
---|---|---|---|---|
LVEDVi, ml/m1.7 | 0.22 | −0.75 (−1.22 to −0.28)* | −0.08 (−0.54 to .39) | … |
LVESVi, ml/m1.7 | 0.19 | 0.27 (−0.01 to 0.55) | 0.46 (0.18 to 0.74)* | … |
LVMi, g/m1.7 | 0.46 | 0.92 (0.41 to 1.42)* | 0.53 (0.12 to 0.95)† | … |
LVMVR, g/ml | 0.24 | 0.039 (0.030 to 0.049)** | 0.015 (0.006 to 0.025)* | … |
LVEF, % | 0.23 | −0.93 (−1.24 to −0.61)** | −0.84 (−1.16 to −0.52)** | −0.86 (−1.17 to −0.55)** |
Ecc, % | 0.25 | 0.69 (0.55 to 0.83)** | 0.55 (0.40 to 0.69)** | 0.48 (0.34 to 0.63)** |
Torsion, °/cm | 0.27 | −0.07 (0.12 to −0.01)† | −0.11 (−0.17 to −0.06)** | −0.11 (−0.16 to −0.06)** |
EDSR, 1/s | 0.12 | −0.007 (−0.009 to −0.005)** | −0.003 (−0.005 to −0.001)† | −0.002 (0.005 to 0.0002) |
Coefficients and 95%CI (in brackets) were estimated using multivariable linear regression models to assess the association of logPWV (per 1 SD) with LV structural and functional variables as dependent variables.
Model 1: unadjusted.
Model 2: adjusted for age, sex, race, smoking, diabetes mellitus, antihypertensive medication, obesity, SBP, heart rate, LDL, HDL, and CVD
Model 3: adjusted for Model2 + LVMi and LVEDVi
CVD indicates cardiovascular disease; other abbreviation as in Table 1.
if p<0.001,
if p<0.01,
if p<0.05